EUVIMED · CrossrefZeitschrift
Journal of Onco-Nephrology
ISSN 2399-3693 · SAGE Publications
Neueste Artikel
Acute kidney injury in a patient with endothelial activation syndrome after hematopoietic stem cell transplantation
Response to “Kinetic sodium equation”
Kinetic sodium equation
Heme-pigment nephropathy after transurethral resection of prostate cancer
Diagnostic use of contrast medium and the kidney: A challenge or a ghost?
Fibroblast growth factor 23–secreting pancreaticobiliary malignancy
Tubulointerstitial and intraglomerular metastasis with subsequent development of tumor lysis syndrome in a patient with advanced metastatic melanoma
Intracapillary monoclonal deposits disease due to B-cell non-Hodgkin lymphoma: A case report and review of the literature
Urothelial cancer: Once there were urologists, now oncologists joined, what about nephrologists?
The adverse kidney effects of cancer immunotherapies
Thrombosis and kidney disease in cancer: comorbidities defining a very high risk patient: A position paper from the Cancer & the Kidney International Network
Tumor-induced osteomalacia
Tubulitis in a patient treated with nivolumab: Case report and literature review
Cancer drugs and the glomerulus
Membranous nephropathy and cancer in the era of PLA 2 R testing
Partial versus radical nephrectomy for renal cell carcinoma
Monoclonal immunoglobulin–associated C3 glomerulopathy and thrombotic microangiopathy: A real association?
A rare case of crystalglobulinemia
High-flux hemodialysis versus glucarpidase for methotrexate-associated acute kidney injury: What’s best?
Paraneoplastic glomerular disease: The struggle is real
Epidemiology of acute kidney injury and associated factors among patients with malignancy: Analysis of hospital inpatient database in Shanghai, China
Diagnosis of non-neoplastic renal diseases in renal mass biopsies
Update on the prevention and treatment of tumor lysis syndrome
A case of multiple myeloma presenting with uric acid kidney stones
Evolution of the kidney–cancer connection
Newer biological agents: CAR T cells, PARP inhibitors, and ALK inhibitors
Predictors of survival in non-metastatic renal cell cancer after surgery: A retrospective analysis
Paraneoplastic glomerulopathy
Tumour incidence in Fabry disease: A cross-sectional study
Hyponatremia in cancer patients: Strategy for safe correction in the hospital
EUVIMED